Article

D-Lactic acid-induced neurotoxicity in a calf model.

College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
AJP Endocrinology and Metabolism (Impact Factor: 4.09). 08/2007; 293(2):E558-65. DOI: 10.1152/ajpendo.00063.2007
Source: PubMed

ABSTRACT Lactic acidosis (DAC) occurs as a complication of short-bowel syndrome in humans and in a variety of other gastrointestinal disorders in monogastrics and ruminants. DAC is associated with signs of impaired central nervous system (CNS) function including ataxia and coma. The objective of this experiment was to determine whether either acidification of nervous tissue or d-lactic acid is responsible for decreased neurological function. Eight Holstein calves (32 +/- 11 days, 70 +/- 10 kg) were surgically catheterized with indwelling intravenous jugular and atlanto-occipital space cerebrospinal fluid (CSF) catheters and infused for 6 h in random order with isomolar dl-lactic acid (dl-LA), l-lactic acid (l-LA), hydrochloric acid (HCl), or saline. dl-LA induced ataxia after 4 h of infusion and produced the greatest obtunding of CNS function (at 7 h, score 8.0 +/- 0.4), whereas the other infusions caused neither ataxia nor scores over 1.5 (P < 0.01 from dl-LA). dl-LA induced significantly less acidemia than HCl (at 6 h pH 7.13 +/- 0.06 and 7.00 +/- 0.04, base excess -16 +/- 1 and -23 +/- 3 mmol/l, bicarbonate 11 +/- 1 and 8 +/- 1 mmol/l respectively, all P < 0.01) but greater than l-LA and saline (P < 0.01). CSF changes followed a similar but less pronounced pattern. Although HCl infusion produced a severe acidemia and CSF acidosis, only minor effects on neurological function were evident suggesting that d-lactate has a direct neurotoxic effect that is independent of acidosis. Conversely, l-LA produced only minor neurological changes.

Download full-text

Full-text

Available from: Saman Abeysekara, Jul 04, 2015
0 Followers
 · 
118 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: OBJECTIVES: To determine whole blood and serum concentrations of L-lactate and serum concentrations of D-lactate in healthy rabbits and compare three methods of analysis for L-lactate measurement. METHODS: Prospective study using 25 rabbits. Concentrations of whole blood L-lactate were measured using a portable analyser and a blood gas analyser. The remainder of the sample was allowed to clot for centrifugation. Serum was stored at -20 degrees C for determination of L- and D-lactate by high-performance liquid chromatography. RESULTS: D-lactate values by high-performance liquid chromatography were 0.17 +/-0.08 mmol/L. L-lactate values were 5.1 (+/-2.1) mmol/L by high-performance liquid chromatography, 6.9 (+/-2.7) mmol/L with the portable analyser and 7 1 (+/-1.6) mmol/L with the blood gas analyser. No significant difference (P>0.05) was found between the two analysers. Significant difference existed between serum L-lactate values obtained by high-performance liquid chromatography and the whole blood values obtained with the blood gas analyser (P<0.01) and portable analyser (P<0.05). CLINICAL SIGNIFICANCE: Serum concentrations of D-lactate in healthy rabbits are in the range of those of other mammals. L-lactate values in healthy rabbits are higher compared with other mammals. Good correlation was found between the portable and blood gas analysers for whole blood L-lactate measurement in healthy rabbits.
    Journal of Small Animal Practice 07/2014; 55(9). DOI:10.1111/jsap.12247
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Acute ruminal acidosis is a metabolic status defined by decreased blood pH and bicarbonate, caused by overproduction of ruminal D-lactate. It will appear when animals ingest excessive amount of nonstructural carbohydrates with low neutral detergent fiber. Animals will show ruminal hypotony/atony with hydrorumen and a typical parakeratosis-rumenitis liver abscess complex, associated with a plethora of systemic manifestations such as diarrhea and dehydration, liver abscesses, infections of the lung, the heart, and/or the kidney, and laminitis, as well as neurologic symptoms due to both cerebrocortical necrosis and the direct effect of D-lactate on neurons. In feedlots, warning signs include decrease in chewing activity, weight, and dry matter intake and increase in laminitis and diarrhea prevalence. The prognosis is quite variable. Treatment will be based on the control of systemic acidosis and dehydration. Prevention is the most important tool and will require normalization of ruminal pH and microbiota. Appropriate feeding strategies are essential and involve changing the dietary composition to increase neutral detergent fiber content and greater particle size and length. Appropriate grain processing can control the fermentation rate while additives such as prebiotics or probiotics can help to stabilize the ruminal environment. Immunization against producers of D-lactate is being explored.
    The Scientific World Journal 01/2014; DOI:10.1155/2014/702572
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Malgré le manque d’études sur ce sujet, le cancer est considéré comme une des principales causes d’hyperlactatémie de type B chez le chien. Les cellules malignes ont une production accrue de lactates secondaire à une glycolyse aérobie accrue, via l’effet Warburg. Les mécanismes ne sont pas encore clairement établis mais certains auteurs suggèrent que le cancer pourrait causer une hyperlactatémie via l’effet Warburg. Cette étude a pour objectif de déterminer si les tumeurs malignes peuvent être associées à une hyperlactatémie cliniquement significative (≥2,5 mmol/L) chez le chien. Trente-sept chiens atteints de tumeurs malignes ont été recrutés (22 atteints de tumeurs hématopoïétiques et 15 de tumeurs non hématopoïétiques). Le diagnostic était confirmé par analyse histologique, ou cytologique en cas de lymphome. Les autres causes possibles d’hyperlactatémie étaient écartées puis la mesure des lactates sanguins était réalisée sur sang veineux jugulaire immédiatement analysé avec le LactatePro®. Aucun chien n’était hyperlactatémique. La concentration moyenne en lactates sanguins était de 1,09 mmol/L. La concentration moyenne en lactates sanguins pour les chiens atteints de tumeurs non hématopoïétiques et hématopoïétiques était respectivement de 0,95 mmol/L et de 1,19 mmol/L. Les chiens atteints de lymphome (n=18) avaient une concentration moyenne en lactates sanguins de 1,15 mmol/L. Les tumeurs malignes ne sont pas associées à une hyperlactatémie de type B cliniquement significative chez le chien. L’hyperlactatémie tumorale est donc une complication rare chez le chien. Son diagnostic devrait conduire à une investigation minutieuse des autres causes d’hyperlactatémie. Cancer is considered a cause of type B hyperlactatemia in dogs. However, studies evaluating cancer as a cause of clinically relevant type B hyperlactatemia (≥2.5 mmol/L) are lacking. It is well accepted that cancer cells have a higher lactate production due to increased aerobic glycolysis, known as the Warburg effect. The mechanisms through which aerobic glycolysis occurs are not well elucidated but it has been suggested that neoplasia may cause type B hyperlactatemia via this process. The aim of this study is to determine if canine malignant tumors could be associated with a clinically relevant type B hyperlactatemia (≥ 2.5 mmol/L). Thirty-seven dogs with malignant tumors were included: 22 with hematopoietic and 15 with solid tumors. Histology was used to confirm the diagnosis (cytology was considered appropriate for lymphoma). Confounding factors associated with hyperlactatemia were excluded. Lactate measurements were obtained from a free flow jugular whole blood sample and immediately analyzed using the LactatePro®. All dogs had lactate values less than 2.5 mmol/L. The mean blood lactate concentration was 1.09 mmol/L. The mean blood lactate concentration for solid and hematopoietic tumor was 0.95 mmol/L and 1.19 mmol/L respectively. Dogs with lymphoma (n = 18) had a mean blood lactate concentration of 1.15 mmol/L. Malignant tumors were not considered a cause of clinically relevant type B hyperlactatemia. Therefore, cancer related type B hyperlactatemia in dogs with cancer is uncommon and its diagnosis should prompt careful investigation for causes other than cancer.